PRMA’s White Outlines Expanded U.S. Presence
PRMA Consulting's Nathan White, senior principal and U.S. practice lead, in a recent interview outlines the agency's latest expansion in [...]
Study: 1 in 5 Encounter Surprise Bills for Surgery
A recent study published in JAMA suggests that 1 in 5 insured patients received a surprise bill following surgery. Researchers [...]
ISPOR-FDA Summit 2020 Nears
A joint summit hosted by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and Food and Drug Administration (FDA) [...]
ISPOR to Host Webinar on Patient-Preference Information
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is set to host a webinar March 4 on patient-preference methods [...]
More on Report from Pioneer Institute on QALY
Pharmaphorum in a recent report highlights a new analysis by the Pioneer Institute that suggests the Institute for Clinical and [...]
Study: $2.5 Billion Spent on SDOH Programs Between 2017-19
A recent study published in Health Affairs suggests organizations spent at least $2.5 billion on programs targeting social determinants of [...]
Analysis Suggests ICER’s QALY Approach Violates ADA
A new analysis by the Pioneer Institute, "The Legality of QALY under the ADA," suggests that the Institute for Clinical [...]
Petition: Allow Registered Reports for Peer Review
A petition on Change.Org is calling for health economics journals to allow registered reports for peer-review. As of this posting, [...]
MM&M Seeking Idea Pitchers for PitchSlam Events
MM&M is inviting people with a knack for pitching ideas to its upcoming PitchSlam events. The competition is for individuals [...]
MM&M Offers eBook Highlighting Data Decoded Conference
MM&M is offering access to an eBook highlighting key takeaways from its Data Decoded conference held in October last year. [...]
AMCP CEO Cantrell Talks Health Care in 2020
Susan Cantrell, CEO of the Academy of Managed Care Pharmacy, in a recent blog post outlines a number of key [...]
NPC Study: Measurement Standards Needed to Assess Direct, Indirect Benefits of Therapies
While therapies capable of mental and physical improvements can see both direct and indirect benefits, measurement standards are necessary to [...]
NPC Webinar to Spotlight Evidence-Based Health Coverage
The National Pharmaceutical Council (NPC) is slated to host a webinar noon EST Feb. 13 highlighting evidence-based coverage decisions by [...]
AMCP Foundation Offering Oncology-Focused Internship
The Academy of Managed Care Pharmacy (AMCP) Foundation, in partnership with Pfizer, announced a new managed care internship focused on [...]
New RWE Company Partnering with Medical Societies for Data
A new real-world evidence company, Verana Health, is partnering with medical societies to obtain data for research in eye disease [...]
NICE Looks to Include EHRs, RWE in Guidance
The U.K.'s National Institute for Health and Care Excellence (NICE) announced plans to incorporate electronic health records and real-world evidence [...]
Report: ICER to Assess RWE on Accelerated Approvals
The Institute for Clinical and Economic Review (ICER) will incorporate real-world evidence into future updates of already-reviewed according to a [...]
Beyond Burnout: Docs Decry ‘Moral Injury’ From Financial Pressures of Health Care
Via Kaiser Health News Dr. Keith Corl was working in a Las Vegas emergency room when a patient arrived with [...]
Dems Invite Insulin Affordability Advocates to State of the Union
A slate of Democratic legislators have invited insulin affordability activists as their guests to tonight's State of the Union address, [...]
ICER Finalizes Updates to Value Assessment Framework
The Institute for Clinical and Economic Review (ICER) on Jan. 31 published an updated version of its value assessment framework [...]
ICER Recommends Major Price Reductions for New Sickle Cell Drugs
The Institute for Clinical and Economic Review (ICER) in a draft report recommended significant price cuts for two sickle cell [...]
Denmark Adopting QALY System for Hospital Drugs
Denmark is shifting to a new evaluation system for hospital drugs based on the quality-adjusted life year (QALY), according to [...]
MCRA Taps McDermott to Head RHEMA Division
Clinical research organization MCRA recently welcomed John McDermott as the senior director of its Reimbursement, Health Economics, and Market Access [...]
MM&M Set to Release Pharma Marketing Trends in March
MM&M announced it would release its flagship report on marketing in the pharmaceutical industry in March. "The proprietary survey of [...]
New Guidance Enables States to Convert Medicaid Funding into Block Grant
A new initiative rolled out earlier this week by Centers for Medicare and Medicaid Services (CMS) aims to let states [...]